Drug Shortage Report for MENVEO

Last updated on 2025-10-27 History
Report ID 266256
Drug Identification Number 02347393
Brand name MENVEO
Common or Proper name Meningococcal (Groups A, C, W-135 and Y) Oligosaccharide CRM-197 Conjugate Vaccine
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN MENINGOCOCCAL GROUP C OLIGOSACCHARIDE MENINGOCOCCAL GROUP W-135 OLIGOSACCHARIDE MENINGOCOCCAL GROUP A OLIGOSACCHARIDE MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE
Strength(s) 47MCG 5MCG 5MCG 10MCG 5MCG
Dosage form(s) POWDER FOR SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1's
ATC code J07AH
ATC description BACTERIAL VACCINES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2025-09-08
Actual start date 2025-09-08
Estimated end date 2025-10-27
Actual end date 2025-10-24
Shortage status Resolved
Updated date 2025-10-27
Company comments Doses reserved for Public programs, supply disruptions may be seen in the private market.
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2025-10-27 French Compare
v8 2025-10-27 English Compare
v7 2025-10-17 French Compare
v6 2025-10-17 English Compare
v5 2025-09-10 French Compare
v4 2025-09-10 English Compare
v3 2025-09-09 English Compare
v2 2025-08-29 French Compare
v1 2025-08-29 English Compare

Showing 1 to 9 of 9